A pro-tumorigenic activity of EXT1 has been reported in a glioblastoma model, since EXT1 knockout reduced cell proliferation in vitro and growth of glioblastoma xenograft in mice by attenuating receptor tyrosine kinase activity [19]. Here, NTRK1 is linked to glioblastoma.